PHARMAGREEN BIOTECH INC. Conversion of Stock, Amount Converted
PHARMAGREEN BIOTECH INC. reported Conversion of Stock, Amount Converted of $4.17 million for the 12-month period ending 2021-09-30, per its 10-K filed 2023-01-17.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockAmountConverted1 · last filed 2023-01-17
- PHARMAGREEN BIOTECH INC. conversion of stock, amount converted for the quarter ending 2021-09-30 was $8.33M, a 4493.58% increase year-over-year.
- PHARMAGREEN BIOTECH INC. conversion of stock, amount converted for the quarter ending 2021-06-30 was -$8.33M, a 8019.39% decline year-over-year.
- PHARMAGREEN BIOTECH INC. conversion of stock, amount converted for the quarter ending 2020-09-30 was $181.39K.
- PHARMAGREEN BIOTECH INC. conversion of stock, amount converted for the quarter ending 2020-06-30 was $105.21K.
- PHARMAGREEN BIOTECH INC. conversion of stock, amount converted for fiscal 2021 was $4.17M, a 1283.68% increase from fiscal 2020.
- PHARMAGREEN BIOTECH INC. conversion of stock, amount converted for fiscal 2020 was $301.09K.
| Period end | Conversion of Stock, Amount Converted 1 month | Conversion of Stock, Amount Converted 3 month | Conversion of Stock, Amount Converted 6 month | Conversion of Stock, Amount Converted 9 month | Conversion of Stock, Amount Converted 12 month |
|---|---|---|---|---|---|
| 2021-09-30 | $8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-17 | $0.00 derived: sum of 2 quarters · filed 2023-01-17 | $4.17M 10-K · filed 2023-01-17 | ||
| 2021-06-30 | -$8.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-08-18 | -$4.17M 10-Q · filed 2021-08-18 | |||
| 2021-03-31 | $4.17M 10-Q · filed 2021-05-24 | ||||
| 2020-09-30 | $181.39K derived: 10-K 12 month − 10-Q 9 month · filed 2021-12-29 | $286.60K derived: sum of 2 quarters · filed 2021-12-29 | $301.09K 10-K · filed 2021-12-29 | ||
| 2020-07-22 | $180.00K 10-K · filed 2021-12-29 | ||||
| 2020-06-30 | $105.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-19 | $119.70K 10-Q · filed 2020-08-19 | |||
| 2020-03-31 | $14.49K 10-Q · filed 2020-05-19 |